These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35504365)

  • 1. Lifetime attributable risk of radiation induced second primary cancer from scattering and scanning proton therapy - A model for out-of-field organs of paediatric patients with cranial cancer.
    Dell'Oro M; Short M; Wilson P; Peukert D; Hua CH; Merchant TE; Bezak E
    Radiother Oncol; 2022 Jul; 172():65-75. PubMed ID: 35504365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the influence of radiosensitivity on development of second primary cancer in out-of-field organs following proton therapy for paediatric cranial cancer.
    Dell'Oro M; Wilson P; Short M; Peukert D; Bezak E
    Br J Radiol; 2023 Oct; 96(1150):20230161. PubMed ID: 37660473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.
    Donovan EM; James H; Bonora M; Yarnold JR; Evans PM
    Med Phys; 2012 Oct; 39(10):5814-24. PubMed ID: 23039620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of long-term risks of secondary cancer in paediatric patients with brain tumours after boron neutron capture therapy.
    Zhang X; Geng C; Tang X; Bortolussi S; Shu D; Gong C; Han Y; Wu S
    J Radiol Prot; 2019 Sep; 39(3):838-853. PubMed ID: 31195386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
    Moteabbed M; Yock TI; Paganetti H
    Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary cancer risk assessments following the proton therapy of lung cancer as the functions of field characteristics and patient age.
    Jia SB; Shamsabadi R
    Int J Radiat Biol; 2024; 100(2):183-189. PubMed ID: 37747407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk estimation of second primary cancers after breast radiotherapy.
    Santos AM; Marcu LG; Wong CM; Bezak E
    Acta Oncol; 2016 Nov; 55(11):1331-1337. PubMed ID: 27379458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
    Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
    J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the radiation-induced second cancer risk in proton therapy for pediatric brain tumors: the impact of employing a patient-specific aperture in pencil beam scanning.
    Geng C; Moteabbed M; Xie Y; Schuemann J; Yock T; Paganetti H
    Phys Med Biol; 2016 Jan; 61(1):12-22. PubMed ID: 26605679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk.
    García-Hernández T; Romero-Expósito M; Sánchez-Nieto B
    Radiother Oncol; 2020 Dec; 153():289-295. PubMed ID: 33065184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scattered dose to radiosensitive organs and associated risk for cancer development from head and neck radiotherapy in pediatric patients.
    Kourinou KM; Mazonakis M; Lyraraki E; Stratakis J; Damilakis J
    Phys Med; 2013 Nov; 29(6):650-5. PubMed ID: 22921884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.
    Tamura M; Sakurai H; Mizumoto M; Kamizawa S; Murayama S; Yamashita H; Takao S; Suzuki R; Shirato H; Ito YM
    J Radiat Res; 2017 May; 58(3):363-371. PubMed ID: 27789564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
    Suleiman SA; Qi Y; Pi Y; George Xu X
    Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
    Bezak E; Takam R; Yeoh E; Marcu LG
    Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.
    Nguyen J; Moteabbed M; Paganetti H
    Med Phys; 2015 Jan; 42(1):81-9. PubMed ID: 25563249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SECOND CANCER RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES.
    Mazonakis M; Kachris S; Damilakis J
    Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.